BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients.
Publication
, Journal Article
Than, H; Lye, WK; Sng, C; Allen, JC; Ong, ST; Chuah, C
Published in: Leuk Lymphoma
January 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
January 2019
Volume
60
Issue
1
Start / End Page
234 / 237
Location
United States
Related Subject Headings
- Young Adult
- Treatment Outcome
- Sequence Deletion
- Prognosis
- Predictive Value of Tests
- Polymorphism, Genetic
- Middle Aged
- Male
- Leukemia, Myeloid, Chronic-Phase
- Kaplan-Meier Estimate
Citation
APA
Chicago
ICMJE
MLA
NLM
Than, H., Lye, W. K., Sng, C., Allen, J. C., Ong, S. T., & Chuah, C. (2019). BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients. Leuk Lymphoma, 60(1), 234–237. https://doi.org/10.1080/10428194.2018.1461863
Than, Hein, Weng K. Lye, Colin Sng, John C. Allen, S Tiong Ong, and Charles Chuah. “BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients.” Leuk Lymphoma 60, no. 1 (January 2019): 234–37. https://doi.org/10.1080/10428194.2018.1461863.
Than H, Lye WK, Sng C, Allen JC, Ong ST, Chuah C. BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients. Leuk Lymphoma. 2019 Jan;60(1):234–7.
Than, Hein, et al. “BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients.” Leuk Lymphoma, vol. 60, no. 1, Jan. 2019, pp. 234–37. Pubmed, doi:10.1080/10428194.2018.1461863.
Than H, Lye WK, Sng C, Allen JC, Ong ST, Chuah C. BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients. Leuk Lymphoma. 2019 Jan;60(1):234–237.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
January 2019
Volume
60
Issue
1
Start / End Page
234 / 237
Location
United States
Related Subject Headings
- Young Adult
- Treatment Outcome
- Sequence Deletion
- Prognosis
- Predictive Value of Tests
- Polymorphism, Genetic
- Middle Aged
- Male
- Leukemia, Myeloid, Chronic-Phase
- Kaplan-Meier Estimate